Status:

WITHDRAWN

Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease

Lead Sponsor:

Coordinación de Investigación en Salud, Mexico

Conditions:

Gastroesophageal Reflux Disease

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Gastroesophageal reflux disease has a high global prevalence, proton pump inhibitors are the cornerstone in the management but 10-20% of the patients are refractory to these, surgical treatment being ...

Detailed Description

Gastroesophageal reflux disease is a disease with high global prevalence, reaching rates of 19.6 and 40% in our country, for which it is one of the most common reasons for medical care and although a ...

Eligibility Criteria

Inclusion

  • Patients of both sexes over 18 years and under 90 years with a diagnosis of GERD and who are under medical treatment and who do not want surgical treatment.
  • Confirmed diagnosis of GERD as follows:
  • Positive pHmetry. Positive endoscopy (Esophagitis grade C, D, stenosis or EB)
  • Esophagogastric junction Hill I-III
  • Total or partial response to proton pump inhibitors
  • Patient who does not wish to take medication for the treatment of gastroesophageal reflux in the long term or indefinitely or refractory GERD

Exclusion

  • Patients who do not accept the signature of the informed consent
  • Postoperative fundoplication patients for GERD
  • Patients with extraesophageal symptoms.
  • Pregnant women.
  • Patients with hiatal hernia larger than 3 cm or Hill type IV.
  • Patients with major esophageal motility disorders.
  • Patients with portal hypertension and presence of esophageal varices
  • Patients with hemophilia or some haematological disorder that is difficult to control
  • Patients with malignant pathology of the esophagus or Gastroesophageal Junction (GEJ).

Key Trial Info

Start Date :

July 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04036942

Start Date

July 15 2019

End Date

April 1 2025

Last Update

April 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centro Medico Nacional Siglo XXI Hospital de Especialidades

Mexico City, Mexico City, Mexico, 06700